SCHEMBL6090926

SCHEMBL6090926

Cc1cccc(C(C)(C)C)c1OCC#N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.43
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
SCN2A Q99250 3/20 0.38
NAMPT P43490 1/20 0.37
NLRP3 Q96P20 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
AR P10275 1/20 0.35
SCN4A P35499 3/20 0.35
LMNA P02545 2/20 0.35
TSHR P16473 2/20 0.35
SCN1A P35498 2/20 0.35
SCN5A Q14524 2/20 0.35
SCN9A Q15858 2/20 0.35
CYP2D6 P10635 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1825131 0.84 SCN4A (0.47) ALDH1A1KDM4ESCN2ACA12CA1
SCHEMBL22096830 0.82 NAMPT (0.53) ALDH1A1SMN1; SMN2KDM4ENAMPTAR
SCHEMBL6089172 0.80 NAMPT (0.35) ALDH1A1SMN1; SMN2KDM4ENAMPTCA2
SCHEMBL6832124 0.76 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2KDM4EGAAGABRA1
SCHEMBL16479215 0.76 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2KDM4EGAAGABRA1
SCHEMBL23491315 0.76 TSHR (0.48) SMN1; SMN2SCN2ACA12CA1CA9
SCHEMBL9921644 0.76 SCN8A (0.40) SCN2ACA12CA1CA9AR
SCHEMBL73389 0.76 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2KDM4EGAAGABRA1
SCHEMBL9186079 0.76 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2KDM4EGAAGABRA1
SCHEMBL11333666 0.75 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2KDM4EGAAGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005440-B1 Therapeutic uses of tri-aryl acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2006-02-28 US disclosed
EP-1177176-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 EP disclosed
WO-2000064876-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed